
MPR Weekly Dose Podcast Episode 39
This week we cover the latest in the rapidly shifting perception of chloroquine and hydroxychloroquine; The polio vaccine as a potential protector against COVID-19; A new approval for Gardasil 9; And ...
19 Jun 20207min

MPR Weekly Dose Podcast Episode 38
This week on the pod we cover the latest COVID19 news, including antibody tests and their accuracy; A study aiming to examine treatments in children; The potential benefit of Acalabrutinib in severe ...
12 Jun 20208min

MPR Weekly Dose Podcast Episode 37
This week on the pod we look at results from a COVID-19 prevention trial of hydroxychloroquine; A vaccine arrival date prediction by Dr Fauci; A FDA notification regarding vial caps; A look into presc...
5 Jun 202010min

MPR Weekly Dose Podcast Episode 36
Today's pod covers important news regarding hydroxychloroquine; The efficacy of dietary supplements as a means to manage or prevent COVID-19; The first non-hormonal contraceptive gel approved by the F...
29 Mai 20208min

MPR Weekly Dose Podcast Episode 35
This week we cover the latest COVID-19 developments including: reports of false negatives with Abbott's diagnostic test; the immune globulin therapy linked to recovery in multisystem inflammatory synd...
22 Mai 20208min

MPR Weekly Dose Podcast Episode 34
This week we cover the latest COVID-19 developments including a triple antiviral therapy that looks promising, Emergency Use Authorizations granted to diagnostics and critical meds, Moderna's investig...
14 Mai 20209min

MPR Weekly Dose Podcast Episode 33
This week we cover the the risk of antihypertensive med use during the pandemic; The Emergency Use Authorization for remdesivir in hospitalized patients with suspected or confirmed COVID-19; The addit...
7 Mai 20208min

MPR Weekly Dose Podcast Episode 32
There has been a lot of recent developments in possible COVID-19 treatments. I'll go over the latest status with remdesivir, hydroxychloroquine, sarilumab, and remestemcel-L, and also the treatment gu...
30 Apr 20209min



















